Revolution Medicines Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Revolution Medicines Inc. Common Stock trades at $191.79 (market cap $40.32B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is the larger of the two by market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| RVMD | VMRK | |
|---|---|---|
Market Cap | $40.32B | $46.41B |
Volume | 4,855,734 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $221.15 | $70.15 |
52-Week Low | $47.50 | $57.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $37.02B | $55.52B |
Dividend Yield | — | 4.68% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →